000
| 01377nam##2200301za#4500 |
---|
001 | 9.573627 |
---|
003 | CaOODSP |
---|
005 | 20210624183805 |
---|
007 | cr ||||||||||| |
---|
008 | 150406|1999||||xxc|||||o f|0| 0 eng|d |
---|
040 | |aCaOODSP|beng |
---|
043 | |an-cn--- |
---|
086 | 1 |aH42-2/67-14-1999E-PDF |
---|
110 | 1 |aCanada.|bHealth Canada. |bTherapeutic Products Directorate. |
---|
245 | 10|aTesting for carcinogenicity of pharmaceuticals / |h[electronic resource]|c[issued by the] Therapeutic Products Programme. |
---|
260 | |aOttawa - Ontario : |bHealth Canada. |c1999, c2000. |
---|
300 | |a16p.|breferences |
---|
490 | 1 |aGuidance for industry|vICH Topic S1B |
---|
500 | |aThe catalogue number (H42–2-67-14-1999E) and ISBN (0-662-28445-3) for the print edition have been incorrectly copied in this electronic publication. |
---|
590 | |a12-14-Supp|b2012-04-10 |
---|
690 | 07|aCancer|2gcpds |
---|
690 | 07|aDrugs|2gcpds |
---|
690 | 07|aPharmaceutical industry|2gcpds |
---|
690 | 07|aTesting|2gcpds |
---|
775 | 08|tÉvaluation de la cancérogénicité des produits pharmaceutiques |w(CaOODSP)9.603791 |
---|
776 | 0#|tTesting for carcinogenicity of pharmaceuticals |w(CaOODSP)9.615042 |
---|
830 | #0|aGuidance for industry ;|vICH Topic S1B|w(CaOODSP)9.506921 |
---|
856 | 40|ahttp://publications.gc.ca|qPDF|s58 KB|uhttps://publications.gc.ca/collections/Collection/H42-2-67-14-1999E.pdf|yICH Topic S1B |
---|